These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Neurological Symptoms of Hypophosphatasia. Taketani T. Subcell Biochem; 2015 Jul 23; 76():309-22. PubMed ID: 26219717 [Abstract] [Full Text] [Related]
16. Improvement of the skeletal and dental hypophosphatasia phenotype in Alpl-/- mice by administration of soluble (non-targeted) chimeric alkaline phosphatase. Gasque KC, Foster BL, Kuss P, Yadav MC, Liu J, Kiffer-Moreira T, van Elsas A, Hatch N, Somerman MJ, Millán JL. Bone; 2015 Mar 23; 72():137-47. PubMed ID: 25433339 [Abstract] [Full Text] [Related]
17. Pyridoxal 5'-phosphate and related metabolites in hypophosphatasia: Effects of enzyme replacement therapy. Akiyama T, Kubota T, Ozono K, Michigami T, Kobayashi D, Takeyari S, Sugiyama Y, Noda M, Harada D, Namba N, Suzuki A, Utoyama M, Kitanaka S, Uematsu M, Mitani Y, Matsunami K, Takishima S, Ogawa E, Kobayashi K. Mol Genet Metab; 2018 Sep 23; 125(1-2):174-180. PubMed ID: 30049651 [Abstract] [Full Text] [Related]
18. Compound heterozygosity of two functional null mutations in the ALPL gene associated with deleterious neurological outcome in an infant with hypophosphatasia. Hofmann C, Liese J, Schwarz T, Kunzmann S, Wirbelauer J, Nowak J, Hamann J, Girschick H, Graser S, Dietz K, Zeck S, Jakob F, Mentrup B. Bone; 2013 Jul 23; 55(1):150-7. PubMed ID: 23454488 [Abstract] [Full Text] [Related]